Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

214.62
Delayed Data
As of 4:00pm ET
 -0.20 / -0.09%
Today’s Change
211.35
Today|||52-Week Range
340.34
-31.32%
Year-to-Date

Today’s Trading

Previous close214.82
Today’s open214.16
Day’s range211.35 - 215.12
Volume3,725,882
Average volume (3 months)4,027,770
Market cap$86.2B
Dividend yield--
Data as of 4:00pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+5.12%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-1.38-1.81%
CELGCelgene-2.32-2.25%
AZNAstraZeneca-0.66-2.28%
ABBVAbbVie-0.31-0.50%
Data as of 4:04pm ET, 05/04/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)$3.04
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
President-Generic &
Global Operations, EVP
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs